Skip Navigation

A Phase II Study of Perioperative mFOLFOX Fluorouracil, Leucovorin, and Oxaliplatin Chemotherapy Plus Pembrolizumab MK-3475 Combination in Patients with Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction GEJ and Stomach MISP 52216

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT03488667

Study #:
STUDY00141863

Start Date:
Jun 26, 2018

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03488667

View Complete Trial Details & Eligibility at ClinicalTrials.gov